在视网膜应用中使用精确基因编辑技术
Mehri Ahmadian1, Iskalen Cansu Topcu Okan1, Gokce Uyanik1
1Molecular Biology, Genetics And Bioengineering Program, Sabanci University, Istanbul, Turkey.
Advances in experimental medicine and biology
|February 10, 2025
概括
基因疗法为遗传视网膜疾病 (IRD) 提供了新的希望. 先进的基因编辑工具,如CRISPR,基因编辑和主要编辑,显示了通过纠正遗传缺陷来治疗IRD的前景.
科学领域:
- 眼科医生 眼科 眼科
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 遗传性视网膜疾病 (IRD) 是视力丧失的重要原因之一.
- 基因疗法,以RPE65基因替代为例,已经在治疗某些IRD方面取得了成功.
- 基因编辑的最新进展提供了超出简单基因替代的新治疗策略.
研究的目的:
- 审查和总结基因组编辑技术的最新进展.
- 评估这些新型基因编辑工具在治疗IRD中的潜在应用.
- 突出主要编辑,基编辑和RNA编辑作为新兴的治疗方式.
主要方法:
- 审查关于基因编辑技术的当前文献.
- 专注于CRISPR-Cas9,基编辑,主要编辑和RNA编辑系统.
- 分析它们的适用性和在视网膜疾病中体内基因改造的潜力.
主要成果:
- 基因编辑技术可以在体内进行精确的基因修改.
- 基因编辑和原始编辑为基因纠正提供了多功能工具.
- RNA编辑提供了一个转录后的方法来纠正突变.
结论:
- 先进的基因编辑技术,包括原始编辑,基因编辑和RNA编辑,对治疗IRD有很大的前景.
- 这些技术为视网膜疾病背后的各种突变提供了精确的基因校正策略.
- 进一步的研究和开发对于将这些编辑工具转化为有效的IRD临床疗法至关重要.
相关概念视频
02:53Conservative Site-specific Recombination and Phase Variation
5.9K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
5.9K
01:59CRISPR
49.1K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.1K